| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Barbara Nowacka, Wojciech Lubiński, Beata Kaźmiercza. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Optic Neuritis - A Case Report and Literature Review. International medical case reports journal. vol 17. 2024-05-06. PMID:38708316. |
myelin oligodendrocyte glycoprotein (mog)-igg-associated optic neuritis (on) is a new subset of demyelinating optic neuropathy. |
2024-05-06 |
2024-05-08 |
Not clear |
| Aniruddh Heroor, Mudit Tyagi, Ramesh Kekunnaya, Goura Chattannava. Paracentral acute middle maculopathy in a patient with Myelin Oligodendrocyte glycoprotein antibody associated optic neuritis. American journal of ophthalmology case reports. vol 34. 2024-04-29. PMID:38680528. |
in this case report, we present a distinctive instance of optic neuritis with a positive myelin oligodendrocyte glycoprotein (mog) antibody, accompanied by retinal ischemia manifesting as paracentral acute middle maculopathy (pamm) lesions. |
2024-04-29 |
2024-05-01 |
Not clear |
| Yoji Hoshina, Meagan Seay, Sravanthi Vegunta, Eric L Stulberg, Melissa A Wright, Ka-Ho Wong, Tammy L Smith, Daisuke Shimura, Stacey L Clard. Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-04-22. PMID:38644536. |
the diagnosis and treatment of autoimmune optic neuritis (on) has improved with the accessibility and reliability of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibody testing, yet autoantibody-negative on remains common. |
2024-04-22 |
2024-04-24 |
Not clear |
| Juan Zhao, Xiaoli Chen, Jingxiao Zhang, Lei Liu, Jiawei Wang, Liping Zh. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Multiple sclerosis and related disorders. vol 85. 2024-03-06. PMID:38447395. |
however, less is known about whether the manifestations of isolated mog antibody-associated optic neuritis (imog-on) vary across different age groups. |
2024-03-06 |
2024-03-09 |
Not clear |
| Ryan D Sorensen, Ashtyn Vogt, Noor Laylani, Mohammad Pakravan, Andrew G Le. Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report. BMC ophthalmology. vol 24. issue 1. 2024-02-13. PMID:38350984. |
myelin oligodendrocyte glycoprotein (mog) associated optic neuritis in a patient with idiopathic intracranial hypertension (iih) and compressive optic neuropathy case report. |
2024-02-13 |
2024-02-16 |
Not clear |
| Takashi Saito, Rieko Suzuki, Noboru Imai, Masahiro Serizaw. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Following Adenovirus Meningitis After First Delivery: Case Report and Literature Review. Cureus. vol 15. issue 11. 2023-12-07. PMID:38060760. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a group of central nervous system (cns) demyelinating diseases caused by autoantibodies against myelin oligosaccharide protein (mog), a myelin sheath component protein, and present with a variety of symptoms, including optic neuritis, myelitis, acute disseminated encephalomyelitis (adem), brainstem encephalitis, and corticobasal encephalitis. |
2023-12-07 |
2023-12-17 |
Not clear |
| Chuan-Bin Su. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection. Frontiers in immunology. vol 14. 2023-12-06. PMID:38054007. |
prevalence of serum mog antibody and aqp4 antibody in optic neuritis after sars-cov-2 infection. |
2023-12-06 |
2023-12-10 |
Not clear |
| Mohamad Azlan Zaini, Ayesha Mohd Zain, Norshamsiah Md Din, Chenshen La. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient. Immunity, inflammation and disease. vol 11. issue 10. 2023-10-31. PMID:37904693. |
we report a case of myelin oligodendrocyte glycoprotein (mog) related optic neuritis in a sars-cov-2 (covid-19) patient. |
2023-10-31 |
2023-11-08 |
Not clear |
| Min Shi, Danqing Luo, Zhaoying Li, Man Li, Shuoguo Jin, Dongdong Yang, Jun Guo, Guo Che. A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis. Frontiers in neurology. vol 14. 2023-10-20. PMID:37859651. |
a case report of neurosyphilis coexisting with a positive mog antibody manifested as optic neuritis. |
2023-10-20 |
2023-11-08 |
Not clear |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
we are reporting a case of a middle-aged adult diagnosed with myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis of the right eye post-covid-19 disease. |
2023-10-09 |
2023-10-15 |
Not clear |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
a diagnosis of mog antibody-positive optic neuritis was made, and the patient was treated with an injection of methylprednisolone with intravenous immunoglobulin. |
2023-10-09 |
2023-10-15 |
Not clear |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (mog) autoantibody-associated disorders focusing on optic neuritis with consideration of autoantibody-binding sites: a review. |
2023-09-09 |
2023-10-07 |
mouse |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
several studies have identified two mog epitopes that exhibit strong affinity with human anti-mog autoantibodies, particularly those isolated from patients with the optic neuritis phenotype. |
2023-09-09 |
2023-10-07 |
mouse |
| Xuelian Chen, Libo Cheng, Ying Pan, Peng Chen, Yidan Luo, Shiyi Li, Wenjun Zou, Ke Wan. Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood. Frontiers in immunology. vol 14. 2023-09-04. PMID:37662934. |
corrigendum: different immunological mechanisms between aqp4 antibody-positive and mog antibody-positive optic neuritis based on rna sequencing analysis of whole blood. |
2023-09-04 |
2023-09-07 |
Not clear |
| D D Eliseeva, A K Kalashnikova, V V Bryukhov, N A Andreeva, N V Zhorzholadze, Yu K Murakhovskaya, T D Krilova, P G Tsygankova, M N Zakharova, N L Shereme. [Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. Vyp. 2. 2023-08-10. PMID:37560844. |
optic neuritis can occur at the onset or be one of the syndromes within multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad). |
2023-08-10 |
2023-08-16 |
Not clear |
| Jessica A Kraker, John J Che. An update on optic neuritis. Journal of neurology. 2023-08-05. PMID:37542657. |
although most cases of optic neuritis (on) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (aqp4)-igg neuromyelitis optica spectrum disorder (nmosd) and the recently described entity, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-08-05 |
2023-08-14 |
Not clear |
| Tomoko Tanaka, Masaya Togo, Kiminobu Okayama, Norio Chihara, Takehiro Ueda, Kenji Sekiguchi, Riki Matsumot. [Cingulate seizure as a clinical manifestation of anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis of two cases]. Rinsho shinkeigaku = Clinical neurology. 2023-07-02. PMID:37394493. |
the first case, a 20-year-old man had been treated with steroids for anti-myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis. |
2023-07-02 |
2023-08-14 |
Not clear |
| Tatsuro Mis. [Myelin Oligodendrocyte Glycoprotein Antibody Associated Disorders]. Brain and nerve = Shinkei kenkyu no shinpo. vol 75. issue 6. 2023-06-08. PMID:37287354. |
the antibody against myelin oligodendrocyte glycoprotein (mog) has been identified for its association with several clinical phenotypes including acute or multiphasic disseminated encephalomyelitis, optic neuritis, nmosd, and brainstem or cerebral cortical encephalomyelitis, and now generally called mog associated disorders (mogad). |
2023-06-08 |
2023-08-14 |
Not clear |
| Kiandokht Keyhanian, Bart K Chwalis. The Treatment of Acute Optic Neuritis. Seminars in ophthalmology. 2023-05-10. PMID:37162276. |
despite the high incidence of optic neuritis (on), and the growing number of therapeutic options for the long-term treatment of diseases associated with on including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd) and mog antibody associated disease (mogad), there are still only limited therapeutic options for treating an acute event of optic neuritis. |
2023-05-10 |
2023-08-14 |
Not clear |
| Yuki Matsumoto, Kimihiko Kaneko, Toshiyuki Takahashi, Yoshiki Takai, Chihiro Namatame, Hiroshi Kuroda, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain : a journal of neurology. 2023-04-16. PMID:37061817. |
the spectrum of myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) includes optic neuritis (on), myelitis (my), acute disseminated encephalomyelitis (adem), brainstem encephalitis, cerebral cortical encephalitis (ce), and aquaporin-4-igg (aqp4-igg)-negative neuromyelitis optica spectrum disorder (nmosd). |
2023-04-16 |
2023-08-14 |
Not clear |